Physician

Abbas Khalil, MD

According to 2025 Medicare claims, Abbas Khalil, MD (NPI: 1093716698) practices hematology/oncology in the Lima, OH market, with the plurality of this provider's patient population coming from Allen, OH. This provider's primary affiliated billing organization is HEMATOLOGY & ONCOLOGY OF LIMA, INC. (NPI: 1366537441) and primary practice location at 45805-2799.

Khalil's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 299 traditional Medicare patients, billed 65,298 HCPCS/CPT codes, and received $1,557,783 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 412 prescription claims across 85 beneficiaries totaling $2,422,363 in drug costs, led by Imbruvica (Ibrutinib). 2020 DME data shows 12 claims. Open Payments data shows 17 records totaling $332. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $844,825 and ending at $1,557,783. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $526,542 to $2,422,363. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$779K$1.6M2015 Medicare payment: $844,825 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,060,725 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,298,658 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,054,008 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,028,594 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $687,147 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $951,804 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,360,141 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,445,810 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,557,783 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015392132,121$844,825
2016430101,337$1,060,725
201744172,703$1,298,658
201838571,862$1,054,008
201939089,158$1,028,594
2020321113,015$687,147
2021311108,623$951,804
202232270,584$1,360,141
202333182,278$1,445,810
202429965,298$1,557,783

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.4M$2.8M2015 Drug cost: $526,542 (USD; Tot_Drug_Cst)2016 Drug cost: $639,382 (USD; Tot_Drug_Cst)2017 Drug cost: $618,576 (USD; Tot_Drug_Cst)2018 Drug cost: $1,123,835 (USD; Tot_Drug_Cst)2019 Drug cost: $971,338 (USD; Tot_Drug_Cst)2020 Drug cost: $1,210,273 (USD; Tot_Drug_Cst)2021 Drug cost: $2,063,186 (USD; Tot_Drug_Cst)2022 Drug cost: $2,785,657 (USD; Tot_Drug_Cst)2023 Drug cost: $2,601,720 (USD; Tot_Drug_Cst)2024 Drug cost: $2,422,363 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201558310$526,542
201655272$639,382
201754298$618,576
201848324$1,123,835
201959268$971,338
202049244$1,210,273
202154293$2,063,186
202265368$2,785,657
202377428$2,601,720
202485412$2,422,363

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$2.0K$4.0K2015 Medicare payment: $4,046 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $1,729 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $1,287 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $355 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $2,230 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R29$4,046
2016N/R17$1,729
2017N/R39$1,287
2018N/R11$355
2019N/RN/RN/R
2020N/R12$2,230
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more2691,046$87
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's144191$12
36415Insertion of needle into vein for collection of blood sample2381,449$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count2371,441$8
J7050Infusion, normal saline solution, 250 cc71733$1

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ImbruvicaIbrutinib35980$552,158
RevlimidLenalidomide23644$392,340
JakafiRuxolitinib Phosphate16480$271,413
BrukinsaZanubrutinib15450$228,944
SprycelDasatinib12360$214,163

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.17$332ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Abbas Khalil, MD?

Tedicare shows public-source Medicare data for Abbas Khalil, MD (NPI 1093716698), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abbas Khalil, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Abbas Khalil, MD?

Abbas Khalil, MD is linked to HEMATOLOGY & ONCOLOGY OF LIMA, INC. (billing NPI 1366537441) in the available physician profile data.

Does Abbas Khalil, MD have Open Payments data?

Abbas Khalil, MD has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.